ResearcherFred Hutch Cancer CenterNo recent work listed
Fadi Braiteh
Matched on ORCID iD 0000-0003-2051-3893; OpenAlex author ID A5104666966, A5104669883. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper
Papers 4
- HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancrea… Co-author DOI 10.1200/jco.2017.74.9564↗
- Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic p… Co-author DOI 10.2147/cmar.s126073↗
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, rand… Co-author DOI 10.1016/s0140-6736(15)00986-1↗
- (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior ther… Co-author DOI 10.1016/j.ejca.2015.06.119↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nathan Bahary · 2 shared papers, 2015–2018 · strength 0.10
- Paper HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Pat… DOI 10.1200/jco.2017.74.9564↗
- Paper (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancre… DOI 10.1016/j.ejca.2015.06.119↗
- Claudio Faria · 1 shared paper, 2017 · strength 0.08
- Manish Patel · 1 shared paper, 2017 · strength 0.08
- Paul S. Ritch · 1 shared paper, 2018 · strength 0.06
- Andrea J. Bullock · 1 shared paper, 2018 · strength 0.06
- Darren S. Sigal · 1 shared paper, 2018 · strength 0.06
- Andrew Eugene Hendifar · 1 shared paper, 2018 · strength 0.06
- Tara Elisabeth Seery · 1 shared paper, 2018 · strength 0.06
- Mark M. Zalupski · 1 shared paper, 2018 · strength 0.06
- Lei Zheng · 1 shared paper, 2018 · strength 0.06
- Andrea Wang‐Gillam · 1 shared paper, 2018 · strength 0.06
- Sunil R. Hingorani · 1 shared paper, 2018 · strength 0.06
- Paul E. Oberstein · 1 shared paper, 2018 · strength 0.06
- Neeta D. Pandit-Taskar · 1 shared paper, 2015 · strength 0.03
- William A. Wegener · 1 shared paper, 2015 · strength 0.03
- Alexander Starodub · 1 shared paper, 2015 · strength 0.03
- Fa-Chyi Lee · 1 shared paper, 2015 · strength 0.03
- Bert H. O’Neil · 1 shared paper, 2015 · strength 0.03
- Donald Richards · 1 shared paper, 2015 · strength 0.03
- Eileen Mary O'Reilly · 1 shared paper, 2015 · strength 0.03
- Ronald Lee Korn · 1 shared paper, 2015 · strength 0.03
- Allyson J. Ocean · 1 shared paper, 2015 · strength 0.03
- Ramesh K. Ramanathan · 1 shared paper, 2015 · strength 0.03
- Maeve Aine Lowery · 1 shared paper, 2015 · strength 0.03
- Tomislav Dragovich · 1 shared paper, 2015 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.